Class II · Moderate risk
Cystex Urinary Pan Relief
cGMP deviations
FDA Drug Recalls
18,003 recalls, newest first
Class II · Moderate risk
Legatrin PM Pain Reliever/Sleep Aid
cGMP deviations
Class II · Moderate risk
Extra Strength
cGMP deviations
Class II · Moderate risk
Chloresin
cGMP deviations
Class II · Moderate risk
Maximum Strength Non Aspirin Pain Reliever/Fever Reducer
cGMP deviations
Class II · Moderate risk
AERO TAB Cold Relief
cGMP deviations
Class II · Moderate risk
Class II · Moderate risk
Nasal & Sinus Decongestant
cGMP deviations
Class II · Moderate risk
Proctofoam HC
cGMP deficiencies
Class III · Low risk
Bortezomib
Failed stability specifications
Class III · Low risk
Azacitidine
Failed stability specifications
Class III · Low risk
Azacitidine
Failed stability specifications
Class II · Moderate risk
Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg
Failed Dissolution Specification: Dissolution results are below specification limits for the active ingredient
Class II · Moderate risk
Moxifloxacin Ophthalmic Solution
Failed Impurities/Degradation Specifications
Class II · Moderate risk
Lexette (halobetasol propionate)
CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.
Class II · Moderate risk
Metoprolol Succinate Extended-Release Tablets
Failed Dissolution Specifications.
Class II · Moderate risk
Lung Cleaner
cGMP deviations
Class II · Moderate risk
8.4% Sodium Bicarbonate Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Tretinoin Capsules
Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.
Class III · Low risk
Mucus Relief D
Subpotent drug
Class II · Moderate risk
Clobetasol Propionate Foam
CGMP Deviations
Class III · Low risk
Class III · Low risk
Class II · Moderate risk
Clobazam Oral Suspension 2.5 mg/mL
Failed Stability Specifications
Class I · High risk
Semglee (insulin glargine)
Labeling: Missing Label: label missing from some Semglee prefilled pens.